Medication-Assisted Treatment: An Interview with Dr. Chad McDonald

Marlene Kurban • September 8, 2021

Medication-assisted treatment (MAT) is the use of medications, in combination with counseling and behavioral therapies, to provide a “whole-patient” approach to the treatment of substance use disorders. At InterCommunity Health Care, MAT programs are clinically driven and tailored to meet each patient’s needs.Research shows that a combination of medication and therapy can successfully treat these disorders, and for some people struggling with addiction, MAT can help sustain recovery. MAT is also used to prevent or reduce opioid overdose.


“Outcomes are so much better with MAT than without medications,” stated Dr. Chad McDonald. Dr. McDonald is Director of Medical Services at InterCommunity Health Care and is an Addiction Specialist and Family Medicine Osteopathic Physician. “Addiction is a chronic brain disease that can be treated and managed with medication, much like other chronic medical conditions. Yet there is still so much stigma experienced by people with addictive disorders. Many of the negative attitudes towards MAT among patients, their doctors, and their peers may come from misunderstandings of how these treatments work.”

The FDA has approved several different medications to treat a wide range of substance use disorders. MAT medications relieve the withdrawal symptoms and psychological cravings that cause chemical imbalances in the body.

“Medications stabilize people,” notes Dr. McDonald. “At InterCommunity, we have the capacity to treat an extended number of people with substance use disorders. For example, all primary care providers at InterCommunity can prescribe Suboxone, which is a combination of buprenorphine and naloxone.”

Suboxone decreases the severity of withdrawal symptoms and reduce a patient’s dependence on opioids in the long term and is taken orally on a daily basis. Another option for patients at InterCommunity is Sublocade (buprenorphine), which is given by injection once a month for adults with moderate to severe opioid use disorder.

Dependence on alcohol or opioids can also be treated with naltrexone , which works by blocking the effect of opioid receptors and decreasing cravings and urges to use alcohol or opioids. Vivitrol, a brand name prescription drug, is naltrexone that is injected intramuscularly once a month.

“There are pros and cons for each medication option. With a once-a-month shot, for example, medication compliance is less of a factor and it’s harder to self-sabotage,” Dr. McDonald stated. “At InterCommunity, we work with every client to find the best solution. There aren’t many organizations that offer such comprehensive addiction services, from detox to intensive and intermediate residential programs and outpatient treatment. We offer truly holistic care and address the social determinants of health.”

Read here for more information on MAT and common misconceptions.

Patients can access care at InterCommunity with or without insurance. Call 860-569-5900 for more information or to schedule an appointment.

May 29, 2025
InterCommunity First to Offer Inpatient Cocaine Withdrawal Management in  Greater Hartford
May 27, 2025
Big Improvements Happening at InterCommunity! 
May 21, 2025
Health, Hope & Healing, One Step at a Time Reflecting on Mental Health Awareness Month at InterCommunity
April 25, 2025
Breathe Easier This Spring: Managing Allergies with InterCommunity
April 24, 2025
InterCommunity’s Journey Forward
March 4, 2025
InterCommunity Celebrates Successful Ribbon-Cutting for Expanded Health Facility
February 26, 2025
Changing the Meaning of Care
February 13, 2025
CT Community Health Centers Navigating Uncertainty, Funding Delays
January 17, 2025
InterCommunity will continue to inspire hope and promote whole-person health by providing high-quality, affordable, compassionate healthcare for everyone.
LDBI Staff
January 6, 2025
For individuals battling opioid addiction, especially those impacted by fentanyl, hope can feel out of reach. InterCommunity Inc. is changing that. As the only provider in the region offering Low-Dose Buprenorphine Induction (LDBI), InterCommunity is leading the way with a safe, more compassionate approach to recovery.
More Posts